CooperCompanies Shares Slide 14% on Weak Q4 Guidance and Strategic Shift
CooperCompanies shares tumbled 14% as weak Q4 guidance and the decision to retain the CooperSurgical unit dashed investor hopes for a strategic…
CooperCompanies shares tumbled 14% as weak Q4 guidance and the decision to retain the CooperSurgical unit dashed investor hopes for a strategic…
Market sentiment soured as energy inflation and geopolitical tensions drove bond yields to multi-year highs, triggering a broad sell-off in technology and…
Major U.S. indexes fell as PPI data pushed rate hike probabilities to 73%, while oil prices surged on geopolitical tensions and retail…
Cooper Companies posted solid Q3 results with record free cash flow, opting to retain its CooperSurgical unit while navigating inventory-related growth constraints…
CooperCompanies beat Q3 earnings estimates despite intentional U.S. inventory reductions, while the board officially ended its strategic review of CooperSurgical to focus…
Cooper Companies stock faces heavy selling pressure after a disappointing Q3 sales report and a downward revision to annual guidance, driven by…